These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 33086429)

  • 61. Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects.
    Muntner P; Mann D; Wildman RP; Shimbo D; Fuster V; Woodward M
    Am Heart J; 2011 Apr; 161(4):719-25. PubMed ID: 21473971
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Frontiers of cardiovascular polypills: From atherosclerosis and beyond.
    Gnanenthiran SR; Agarwal A; Patel A
    Trends Cardiovasc Med; 2023 Apr; 33(3):182-189. PubMed ID: 34973412
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The cost implications of a polypill for primary prevention in the TIPS-3 trial.
    Lamy A; Tong W; Joseph P; Gao P; Pais P; Lopez-Jaramillo P; Walli-Attaei M; Dans AL; Xavier D; Talukder S; Santoso A; Gamra H; Yusuf S
    Eur Heart J Qual Care Clin Outcomes; 2022 Nov; 8(8):899-908. PubMed ID: 34962984
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Polypills: essential medicines for cardiovascular disease secondary prevention?
    Huffman MD; Yusuf S
    J Am Coll Cardiol; 2014 Apr; 63(14):1368-70. PubMed ID: 24561141
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Polypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country.
    Yan LD; Rouzier V; Pierre JL; Dade E; Sufra R; Huffman MD; Apollon A; St Preux S; Metz M; Sabwa S; Morisset B; Deschamps M; Pape JW; McNairy ML
    Front Epidemiol; 2022; 2():. PubMed ID: 36816341
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polypill-based strategy vs. usual care for secondary prevention of cardiovascular disease: a meta-analysis of randomized controlled trials.
    Rivera A; Campos B; Ceolin S; Godoi A; Castanha E; Campello Jorge CA; Cardoso R
    Eur J Prev Cardiol; 2023 Nov; 30(16):1828-1837. PubMed ID: 37490769
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Examining the Use of a Polypill in Cardiovascular Disease Prevention.
    Wang A; Veasaw K; Subhan S; Patel J; Frishman WH
    Cardiol Rev; 2023 Jul; ():. PubMed ID: 37401822
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical Effectiveness of the Cardiovascular Polypill in a Real-Life Setting in Patients with Cardiovascular Risk: The SORS Study.
    Castellano JM; Verdejo J; Ocampo S; Rios MM; Gómez-Álvarez E; Borrayo G; Ruiz E; Ibáñez B; Fuster V;
    Arch Med Res; 2019 Jan; 50(1):31-40. PubMed ID: 31101241
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Could the polypill improve adherence? The patient perspective.
    Bryant L; Martini N; Chan J; Chang L; Marmoush A; Robinson B; Yu K; Wong M
    J Prim Health Care; 2013 Mar; 5(1):28-35. PubMed ID: 23457692
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill.
    Lafeber M; Spiering W; Visseren FL; Grobbee DE
    Curr Hypertens Rep; 2016 Apr; 18(5):40. PubMed ID: 27083928
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Redefining the polypill: pros and cons in cardiovascular precision medicine.
    Birla S; Angural A; Madathumchalil A; Shende RV; Shastry SV; Mahadevappa M; Shambhu SK; Vishwanath P; Prashant A
    Front Pharmacol; 2023; 14():1268119. PubMed ID: 37799963
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease.
    Lafeber M; Webster R; Visseren FLj; Bots ML; Grobbee DE; Spiering W; Rodgers A;
    Eur J Prev Cardiol; 2016 Aug; 23(12):1289-97. PubMed ID: 26743587
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The cardiovascular polypill: clinical data and ongoing studies.
    Castellano JM; Bueno H; Fuster V
    Int J Cardiol; 2015 Dec; 201 Suppl 1():S8-14. PubMed ID: 26747391
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Polypill: A New Alternative in the Prevention and Treatment of Cardiovascular Disease.
    Espinosa EVP; Matute EM; Sosa Guzmán DM; Khasawneh FT
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892892
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials.
    Elley CR; Gupta AK; Webster R; Selak V; Jun M; Patel A; Rodgers A; Thom S
    PLoS One; 2012; 7(12):e52145. PubMed ID: 23284906
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Cardiovascular polypill in high risk patients].
    Lafeber M; Spiering W; Bots ML; de Valk V; Visseren FL; Grobbee DE
    Ned Tijdschr Geneeskd; 2011; 155(44):A3070. PubMed ID: 22067559
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review.
    Lopez-Lopez JP; Gonzalez AM; Lanza P; Lopez-Jaramillo P
    Vasc Health Risk Manag; 2023; 19():605-615. PubMed ID: 37719697
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
    Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
    Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Polypill eligibility and equivalent intake in a Swiss population-based study.
    Castioni J; Abolhassani N; Vollenweider P; Waeber G; Marques-Vidal P
    Sci Rep; 2021 Mar; 11(1):6880. PubMed ID: 33767231
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial.
    Laba TL; Hayes A; Lo S; Peiris DP; Usherwood T; Hillis GS; Rafter N; Reid CM; Tonkin AM; Webster R; Neal BC; Cass A; Patel A; Rodgers A; Jan S
    Med J Aust; 2014 Dec; 201(11):671-3. PubMed ID: 25495315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.